Rodriguez-Berriguete, G., Puliyadi, R., Machado, N., Barberis, A., Prevo, R., McLaughlin, M., . . . Higgins, G. S. (2024). Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease, 15(1), 32-10. https://doi.org/10.1038/s41419-023-06405-8
Chicago-Zitierstil (17. Ausg.)Rodriguez-Berriguete, Gonzalo, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M. Buffa, Kevin J. Harrington, und Geoff S. Higgins. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease 15, no. 1 (2024): 32-10. https://doi.org/10.1038/s41419-023-06405-8.
MLA-Zitierstil (9. Ausg.)Rodriguez-Berriguete, Gonzalo, et al. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease, vol. 15, no. 1, 2024, pp. 32-10, https://doi.org/10.1038/s41419-023-06405-8.